Project Number 3R44AG049510-02S1 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for CLINICAL EVALUATION OF T3D-959 AS A POTENTIAL DISEASE REMEDIAL THERAPEUTIC FOR THE TREATMENT OF ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator DIDSBURY, JOHN Principal Investigator First Name JOHN Principal Investigator Last Name DIDSBURY Awardee Organization T3D THERAPEUTICS, INC. Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PA-14-077: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp) FY Overall Cost $100,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
